Full-Year Financial Results and Cash Flow
Full-year total revenues of $266 million and AFFO of $205 million; generated approximately $200 million of cash flows from operations in 2025; returned $1.1 billion to shareholders since inception.
Quarterly Improvement in AFFO
Q4 2025 AFFO of $53.3 million ($1.88 per share), a 10% improvement versus Q3 2025 AFFO of $1.71 per share; Q4 total revenues of $66.7 million.
Leasing and Re-tenanting Momentum
Executed new leases at 4 properties totaling ~339,000 sq ft in 2025 and progressed on leases/LOIs representing over 900,000 sq ft related to previously nonperforming assets (Forefront, Gold Flora, PharmaCann). Specific wins include 70k and 204k sq ft leases in Palm Springs/Desert Hot Springs and a tentative agreement for a 114k sq ft Washington property.
Capital Deployment and Strategic Investment
Committed ~$275 million in new investments in 2025, including a strategic investment in IQHQ; have funded $150 million of a $270 million commitment to IQHQ (≈55.6% funded) with $120 million remaining to be funded over time.
Improved Liquidity and Access to Capital
Exited the quarter with total liquidity exceeding $105–$107 million (cash + available revolvers); added a $100 million revolving credit facility secured by IQHQ at a 6.1% rate; raised over $145 million of attractively priced debt and preferred equity since October 2025.
Preferred Equity Issuances and Investor Demand
Issued approximately $5 million on ATM in Q4 2025 and raised over $40 million of preferred stock early in Q1 2026 at a yield of just over 9.5%; Series A preferred outstanding grown to $95 million of par value.
Balance Sheet Strength
Portfolio >$2.5 billion gross assets and over $2 billion of unencumbered real estate; conservative capital structure with debt service coverage >10x and net debt to adjusted EBITDA of 1.4x.
Portfolio Dispositions and Capital Recycling
Closed on 3 dispositions in 2025 (California, Colorado, Michigan) and sold a dispensary in Phoenix in early 2026 to opportunistically prune noncore assets and redeploy capital.
Legal Recovery Win
Obtained a $7 million judgment for unpaid rent and damages from former tenant Temescal Wellness (Massachusetts property).
Positive Life-Science Market Signals
Strategic life-science exposure supported by industry stabilization: construction pipeline down from >37M sq ft (2023 peak) to ~6M sq ft (an ≈83.8% decline), Boston annual new demand of 2.1M sq ft (≈72% increase vs 2024), and first Q4 vacancy decline in the San Francisco Peninsula in >2 years.